At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 60 enrolled
Drug / intervention
Acyclovir patch +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode
In Brief
A Phase 1 clinical trial evaluating Acyclovir patch and Placebo patch for Herpes Labialis. Completed, enrolled 60 participants across 1 site.
Detailed Summary
This study will treat approximately 24 participants who experience cold sores. Patches will be applied to the cold sore for up to ten days, and the symptoms will be measured during daily clinic visits using non-invasive measurement techniques.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHerpes Labialis
CountriesGermany
CollaboratorsLabtec GmbH
Timeline
Phase 1CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2012
First PostedJul 2012
Primary CompletionSep 2012
TodayJul 2026
First PostedJul 31, 2012
Enrollment StartJul 1, 2012
Primary CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 13.9 years ago
Interventions
Acyclovir patchdevice
Patch containing acyclovir
Placebo patchdevice
Patch without acyclovir